GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (WBO:NZYM) » Definitions » Capital Expenditure

Novonesis AS (WBO:NZYM) Capital Expenditure : €-275.97 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Novonesis AS Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Novonesis AS's cash flow for capital expenditures for the three months ended in Dec. 2023 was €-81 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was €-275.97 Mil.

Novonesis AS Capital Expenditure Historical Data

The historical data trend for Novonesis AS's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Capital Expenditure Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -133.47 -126.35 -166.75 -388.47 -275.85

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -120.98 -57.50 -73.74 -63.69 -81.04

Novonesis AS Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-275.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis AS (WBO:NZYM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (WBO:NZYM) » Definitions » Capital Expenditure
Comparable Companies
OCSE:SPG OCSE:FLUG B OCSE:HOVE LIN XPAR:AI SHW ECL APD XSWX:SIKA XSWX:GIVN SHSE:600309 PPG LYB BOM:500820 DD ISX:TPIA IFF ADX:BOROUGE WLK NSE:PIDILITIND
Traded in Other Exchanges
NVZMY:USA NVZMF:USA NZYM:Mexico NZYMBc:UK 0Q4U:UK NZYM B:Denmark NZM2:Germany
Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Website
https://www.novozymes.com
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (WBO:NZYM) Headlines

No Headlines